Published by Brainiac Behavioral Health
If you are reading this, you have likely been searching for something different.
Perhaps you have tried four, five, or even six different antidepressants. Perhaps you have been through rounds of therapy, adjusted your sleep hygiene, and committed to exercise—yet the weight of depression remains. Perhaps you have started to believe that nothing will ever change.
You are not alone, and you are not out of options.
At Brainiac Behavioral Health, with locations in Orange, CA (2230 W Chapman Ave, Suite 210C)and Anaheim, CA (160 S Old Springs Rd Suite 135C) , we specialize in treatment-resistant depression. We understand the frustration of medications that stop working—or never worked at all.
That is why we are proud to offer Spravato® (esketamine) , a revolutionary, fast-acting nasal spray treatment for adults with treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal thoughts or actions.
This is not a traditional antidepressant. It does not take weeks to work. It is not “one more pill” to add to the nightly rotation. Spravato represents a paradigm shift in psychiatric care—and we are here to guide you through it.
Table of Contents
- What is Spravato® (Esketamine)?
- How is Spravato Different from Traditional Antidepressants?
- The Science: How Does Esketamine Work?
- Who is a Candidate for Spravato?
- What Does a Spravato Treatment Session Look Like?
- The REMS Program: Safety First
- Spravato vs. Ketamine: What’s the Difference?
- What to Expect: The Patient Experience
- Frequently Asked Questions (FAQ)
- Hope is a Treatment Plan: Contact Brainiac Behavioral Health
1. What is Spravato® (Esketamine)?
Spravato (esketamine) is a FDA-approved nasal spray derived from ketamine, a decades-old anesthetic agent. It was specifically developed for two indications:
- Treatment-Resistant Depression (TRD): For adults who have not responded adequately to at least two oral antidepressants.
- Major Depressive Disorder with Acute Suicidal Ideation or Behavior: For adults who require rapid symptom relief in a psychiatric crisis.
Spravato is not a first-line treatment. It is reserved for those who have tried standard therapies without success. However, for this population, it offers something unprecedented: rapid symptom reduction, often within 24 hours of the first dose .
At Brainiac Behavioral Health, we view Spravato as a lifeline for patients who have felt hopeless after years of trial-and-error prescribing.
2. How is Spravato Different from Traditional Antidepressants?
To understand why Spravato is revolutionary, you must first understand the limitations of conventional antidepressants.
| Feature | Traditional Antidepressants (SSRIs/SNRIs) | Spravato (Esketamine) |
|---|---|---|
| Mechanism | Targets serotonin or norepinephrine | Targets glutamate (NMDA receptor) |
| Onset of Action | 4–6 weeks (often longer) | Hours to days |
| Administration | Daily oral pill | In-office nasal spray (1–2x weekly) |
| Side Effects | Weight gain, sexual dysfunction, emotional numbing | Dissociation, sedation, increased BP (transient) |
| Discontinuation | Tapering often required; withdrawal possible | No physical dependence; abrupt stop safe |
The Bottom Line: SSRIs slowly change neurotransmitter levels over weeks. Spravato rapidly changes neurotransmitter receptor function and promotes synaptic connectivity almost immediately .
3. The Science: How Does Esketamine Work?
Esketamine is the S-enantiomer of ketamine, meaning it is a more potent variant of the racemic mixture. While traditional antidepressants work by increasing serotonin (or norepinephrine) available in the synapse, Spravato targets a completely different system: glutamate.
The Mechanism:
- Spravato binds to and blocks the NMDA receptor on neurons.
- This blockade triggers a cascade of glutamate release.
- Glutamate activates AMPA receptors, which strengthen synaptic connections.
- This leads to the release of Brain-Derived Neurotrophic Factor (BDNF) —essentially “fertilizer” for brain cells.
- Within hours, neurons begin forming new connections (synaptogenesis), reversing the neural atrophy caused by chronic stress and depression .
Why Speed Matters:
In a suicidal patient, waiting four weeks for an SSRI to work is not acceptable. Spravato’s ability to rebuild neural architecture in hours is not just convenient—it is life-saving.
4. Who is a Candidate for Spravato?
Spravato is a specialized treatment reserved for specific clinical scenarios. At Brainiac Behavioral Health, we conduct thorough psychiatric evaluations to determine candidacy.
You may be a candidate if:
- You have been diagnosed with Major Depressive Disorder.
- You have tried at least two different antidepressants at adequate doses and durations without satisfactory improvement.
- You are currently experiencing a major depressive episode.
- You are 18 years of age or older.
You may also be a candidate if:
- You are experiencing acute suicidal thoughts or behaviors and require rapid stabilization.
Important Exclusion Criteria:
- History of aneurysmal vascular disease or intracerebral hemorrhage.
- Known hypersensitivity to esketamine or ketamine.
- Uncontrolled hypertension.
Spravato is administered exclusively in a certified medical office under the FDA’s REMS program. It is not available at retail pharmacies.
5. What Does a Spravato Treatment Session Look Like?
At Brainiac Behavioral Health, we prioritize patient comfort, education, and safety. Here is what you can expect during a typical Spravato session:
Before the Session:
- You will be advised not to eat for at least 2 hours before treatment and to avoid liquids for 30 minutes prior.
- Arrange for a responsible adult to drive you home—you cannot drive or operate machinery for the remainder of the day.
- Take your regular oral antidepressant as prescribed (Spravato is always used in conjunction withan oral antidepressant).
The Session:
- Vital Signs Check: Blood pressure is measured before administration.
- Administration: You will self-administer the nasal spray under the direct supervision of a medical provider. Each spray device delivers a fixed dose; you will be guided through the process.
- Monitoring: You will remain in a comfortable, private room for at least 2 hours while we monitor your blood pressure and check for side effects.
- Dissociation: Many patients experience a feeling of “floating” or disconnection during the first hour. This is normal, temporary, and often resolves before the monitoring period ends.
- Reassessment: Before discharge, your blood pressure is rechecked and you are evaluated for readiness to leave with your driver.
Dosing Schedule (Induction Phase):
- Weeks 1–4: Twice per week.
- Weeks 5–8: Once per week.
- Maintenance: Once every 1–2 weeks, depending on response.
6. The REMS Program: Safety First
Because Spravato can cause sedation, dissociation, and blood pressure elevation, it is only available through a restricted program called the REMS (Risk Evaluation and Mitigation Strategy) .
What REMS means for you:
- Spravato is only dispensed to patients enrolled in the REMS program.
- It is administered only in certified healthcare settings (like Brainiac Behavioral Health).
- All doses are tracked in a national database to prevent misuse.
- Patients must sign an agreement acknowledging the risks and requirements.
This is not a barrier; it is a protection. The REMS program ensures that you receive Spravato in the safest possible environment, surrounded by professionals trained to manage its effects.
7. Spravato vs. Ketamine: What’s the Difference?
Many patients ask about the difference between Spravato and IV ketamine infusions offered at standalone clinics.
| Feature | Spravato (Esketamine) | IV Ketamine (Racemic) |
|---|---|---|
| FDA Status | FDA-approved for TRD and suicidal depression | Off-label; no FDA approval for psychiatric use |
| Enantiomer | S-ketamine (more potent) | R+S ketamine (racemic) |
| Administration | Intranasal (self-administered) | Intravenous (IV drip) |
| Setting | Doctor’s office; 2-hour monitoring | Clinic or spa; variable monitoring |
| Insurance | Often covered by commercial insurance and Medicare | Typically out-of-pocket ($$$) |
| Regulation | Strict REMS program | Variable by state |
The Verdict: While both have their place, Spravato offers the security of FDA approval, insurance coverage, and standardized protocols. At Brainiac Behavioral Health, we choose Spravato because it democratizes access to ketamine-based treatment.
8. What to Expect: The Patient Experience
We believe in transparency. Spravato is not a “magic bullet,” and it is not for everyone. However, for those who respond, the results can be transformative.
The First Session:
Most patients report feeling “different” within hours. Not euphoric, but… lighter. The noise quiets. Suicidal thoughts, for many, lose their urgency.
The First Month:
As sessions continue, the benefits often deepen. Patients describe:
- Returning to hobbies they abandoned years ago.
- Improved sleep and appetite.
- Less rumination and self-criticism.
- The ability to actually use the coping skills they learned in therapy.
The Maintenance Phase:
Once stabilized, patients transition to weekly or biweekly maintenance. Some require ongoing treatment; others are able to taper with their psychiatrist’s guidance.
A Note on Therapy:
Spravato is most effective when combined with concurrent psychotherapy. At Brainiac Behavioral Health, we encourage patients to engage in regular therapy to solidify the neuroplastic changes Spravato facilitates.
Frequently Asked Questions (FAQ)
Q: Is Spravato the same as the “club drug” Special K?
A: Absolutely not. While ketamine is the same base molecule, Spravato is a pharmaceutical-grade, FDA-approved medication administered in precise doses under medical supervision. The context, dose, and route of administration are completely different from recreational use.
Q: How quickly does Spravato work?
A: In clinical trials, some patients experienced symptom relief within 24 hours of the first dose. This is unprecedented compared to traditional antidepressants, which take 4–6 weeks.
Q: Does insurance cover Spravato?
A: Yes. Spravato is covered by many commercial insurance plans and Medicare Part B. Our administrative team at (714) 333-0891 will verify your benefits before you begin treatment.
Q: What are the side effects?
A: The most common side effects are dissociation, dizziness, nausea, sedation, and increased blood pressure. These effects are transient—peaking around 40 minutes and resolving within 1.5–2 hours. Serious side effects are rare in the monitored medical setting.
Q: Can I drive myself home?
A: No. You must arrange for a ride home after each session. You cannot drive or operate heavy machinery for the remainder of the day.
Q: Do I have to stop my current antidepressant?
A: No. Spravato is FDA-approved for use in conjunction with an oral antidepressant. You will continue your current medication unless your psychiatrist advises otherwise.
Q: How long does the entire appointment take?
A: Plan for approximately 2.5 to 3 hours from check-in to discharge. This includes pre-treatment vitals, the spray administration, and the mandatory 2-hour monitoring period.
Q: Is Spravato addictive?
A: When used as prescribed in a medical setting, the risk of addiction is extremely low. Spravato is not self-administered at home, and the REMS program tracks all usage. Unlike opioids or benzodiazepines, esketamine does not produce physical dependence requiring tapering.
Q: What if Spravato doesn’t work for me?
A: Not every patient responds to Spravato. However, clinical trials showed that a significant percentage of treatment-resistant patients achieved remission. If you do not respond, our providers at Brainiac will work with you to pivot to alternative evidence-based treatments, including TMS or medication optimization.
Hope is a Treatment Plan: Contact Brainiac Behavioral Health
For too long, treatment-resistant depression was met with a shrug. “We’ve tried everything.” “Maybe this is just how you are.” “You just need to try harder.”
That is not care. That is surrender.
At Brainiac Behavioral Health, we do not surrender. We believe that every patient deserves access to the full spectrum of modern psychiatric treatment—including revolutionary options like Spravato.
If you are ready to move beyond the limitations of traditional antidepressants, we are ready to walk with you.
📍 Orange Office:
2230 W Chapman Ave, Suite 210C
Orange, CA 92868
📍 Anaheim Office:
160 S Old Springs Rd Suite 135C
Anaheim, CA 92808
📞 Phone: (714) 333-0891
🌐 Web: www.brainiacbehavioralhealth.com
Your depression is treatment-resistant. Your hope does not have to be.